Proteogenomics: Opportunities and Caveats.
| Publicado en: | Clinical Chemistry Vol. 62; no. 4; pp. 551 - 558 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Oxford University Press / USA
Apr2016
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=116360591&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 116360591 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 00099147 10CS jtl: Clinical Chemistry issn: 00099147 maglogo: N pubinfo: dt: Apr2016 vid: 62 iid: 4 pid: 622 pub: Oxford University Press / USA artinfo: ui: 116360591 10.1373/clinchem.2015.247858 116360591 ppf: 551 ppct: 7 formats: fmt: @attributes: type: P tig: atl: Proteogenomics: Opportunities and Caveats. aug: au: Dimitrakopoulos, Lampros Prassas, Ioannis Diamandis, Eleftherios P. Nesvizhskii, Alexey Kislinger, Thomas Jaffe, Jacob Drabovich, Andrei affil: Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|